Essential Oncology for Health Professionals

著者: Pandha, Hardev, Lemoine, Nick
出版事項 1995

PBX3 in Cancer

著者: Morgan, Richard, Pandha, Hardev S
出版年 Cancers (Basel) (2020)

Recent developments and current status of gene therapy using viral vectors in the United Kingdom

著者: Relph, Kate, Harrington, Kevin, Pandha, Hardev
出版事項 2004

Calcium insensitivity of FA-6, a cell line derived from a pancreatic cancer associated with humoral hypercalcemia, is mediated by the significantly reduced expression of the Calciu...

著者: Morgan, Richard, Fairfax, Benjamin, Pandha, Hardev S
出版事項 2006

HG-38 INHIBITING PBX-HOX BINDING IN PAEDIATRIC GLIOMA STEM CELLS AS A NOVEL THERAPEUTIC TREATMENT IN GLIOBLASTOMA

著者: Rogers, William, Morgan, Richard, Pandha, Hardev
出版年 Neuro Oncol (2016)

Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinoma

著者: Iyer, Ridhima, Montgomery, Bruce, Pandha, Hardev S.
出版年 Indian J Urol (2017)

Oncolytic Viruses: Time to Compare, Contrast, and Combine?: 5th International Meeting on Replicating Oncolytic Virus Therapeutics Banff, Alberta, Canada, 18–22 March 2009

著者: Pandha, Hardev, Melcher, Alan, Harrington, Kevin, Vile, Richard
出版事項 2009

Basaloid carcinoma of the prostate: A literature review with case report

著者: Tuan, Jeffrey, Pandha, Hardev, Corbishley, Cathy, Khoo, Vincent
出版事項 2012

Live viruses to treat cancer

著者: Donnelly, Oliver, Harrington, Kevin, Melcher, Alan, Pandha, Hardev
出版事項 2013

Activation and Genetic Modification of Human Monocyte-Derived Dendritic Cells using Attenuated Salmonella typhimurium

著者: Michael, Agnieszka, John, Justin, Meyer, Brendan, Pandha, Hardev
出版年 ScientificWorldJournal (2010)

Modifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response

著者: Annels, Nicola E., Simpson, Guy R., Pandha, Hardev
出版年 Front Oncol (2020)

Kinase Regulation of HOX Transcription Factors

著者: Primon, Monika, Hunter, Keith D., Pandha, Hardev S., Morgan, Richard
出版年 Cancers (Basel) (2019)

The Hitchhiker's Guide to Virotherapy

著者: Donnelly, Oliver, Vile, Richard, Pandha, Hardev, Harrington, Kevin, Melcher, Alan
出版事項 2012

Breaking androgen receptor addiction of prostate cancer by targeting different functional domains in the treatment of advanced disease

著者: Maylin, Zoe R, Nicolescu, Radu CB, Pandha, Hardev, Asim, Mohammad
出版年 Transl Oncol (2021)

Targeting HOX and PBX transcription factors in ovarian cancer

著者: Michael Agnieszka, Harrington Kevin J, Plowright Lynn, Morgan Richard, Pandha Hardev S
出版事項 2010-03-01

Targeting HOX and PBX transcription factors in ovarian cancer

著者: Morgan, Richard, Plowright, Lynn, Harrington, Kevin J, Michael, Agnieszka, Pandha, Hardev S
出版事項 2010

Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances

著者: Simpson, Guy R, Relph, Kate, Harrington, Kevin, Melcher, Alan, Pandha, Hardev
出版年 Oncolytic Virother (2016)

Membrane insertion and secretion of the Engrailed-2 (EN2) transcription factor by prostate cancer cells may induce antiviral activity in the stroma

著者: Punia, Natasha, Primon, Monika, Simpson, Guy R., Pandha, Hardev S., Morgan, Richard
出版年 Sci Rep (2019)

Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo

著者: Anesti, Anna-Maria, Simpson, Guy R, Price, Toby, Pandha, Hardev S, Coffin, Robert S
出版事項 2010

Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients

著者: Pandha, Hardev, Harrington, Kevin, Ralph, Christy, Melcher, Alan, Grose, Mark, Shafren, Darren
出版年 J Immunother Cancer (2015)